XML 16 R4.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Statement of Comprehensive Income [Abstract]    
Collaboration and license revenue $ 400 $ 5,840
Grant revenue 700 0
Total revenue 1,100 5,840
Operating expenses:    
Research and development 14,674 9,738
General and administrative 8,315 9,450
Total operating expenses 22,989 19,188
Operating loss (21,889) (13,348)
Interest income 2,015 1,164
Change in fair value of warrant liabilities 1,818 1,042
Change in fair value of contingent value right liability 346 (39,300)
Change in fair value of forward contract liabilities 0 (6,890)
Other income, net 0 508
Net loss (17,710) (56,824)
Other comprehensive loss:    
Foreign currency translation adjustment 32 (5)
Total comprehensive loss (17,678) (56,829)
Net loss $ (17,710) $ (56,824)
Net loss per share allocable to common stockholders:    
Basic (in dollars per share) $ (0.68) $ (10.50)
Diluted (in dollars per share) $ (0.68) $ (10.50)
Weighted-average common shares outstanding:    
Basic (in shares) 25,902,650 5,414,020
Diluted (in shares) 25,902,650 5,414,020